NASDAQ: LSTA
Lisata Therapeutics Inc Stock Ownership - Who owns Lisata Therapeutics?

Insider buying vs selling

Have Lisata Therapeutics Inc insiders been buying or selling?

Buy
Sell
NameRoleDateSharesPriceValue
David J. MazzoPresident CEO2025-01-103,106$3.73
$11.59kSell
Kristen K. BuckEVP RD and CMO2025-01-10456$3.73
$1.70kSell
James NiscoSVP FinTreas Chief Actg Off2025-01-10416$3.73
$1.55kSell
David J. MazzoPresident CEO2025-01-099,414$3.80
$35.77kSell
David J. MazzoPresident CEO2025-01-0910,925$3.80
$41.52kSell
Kristen K. BuckEVP RD and CMO2025-01-092,651$3.80
$10.07kSell
James NiscoSVP FinTreas Chief Actg Off2025-01-092,131$3.80
$8.10kSell
James NiscoSVP FinTreas Chief Actg Off2025-01-091,137$3.80
$4.32kSell
James NiscoSVP FinTreas Chief Actg Off2025-01-09781$3.80
$2.97kSell
David J. MazzoPresident CEO2025-01-097,017$3.80
$26.66kSell

1 of 2

LSTA insiders have sold more... subscribe to Premium to read more.
Net Insider Buy/Sell (L12M) Ownership

Be the first to know when LSTA insiders and whales buy or sell their stock.

LSTA Shareholders

What type of owners hold Lisata Therapeutics Inc stock?

Institutional
Insider
Retail
NameHoldSharesValueType
Rimasia Capital Partners Manager Ltd279.26%24,632,862$49.51MInsider
Jr Family Trust Aholt140.04%12,352,227$24.83MInsider
Robert Joseph Aholt Jr.132.10%11,652,230$23.42MInsider
Caribbean Stem Cell Group Inc70.86%6,250,000$12.56MInsider
Eric Wei51.59%4,550,499$9.15MInsider
Enhance Biomedical Holdings Ltd45.35%4,000,000$8.04MInsider
Mingsheng Shi43.37%3,825,770$7.69MInsider
Jian M. Zhang43.37%3,825,770$7.69MInsider
Fullbright Finance Ltd34.55%3,047,432$6.13MInsider
Wayne A. Marasco30.46%2,686,713$5.40MInsider

1 of 3

LSTA vs Biotech Stocks

TickerInst. %Insider %Net Insider (L12M)Net Insider (L3M)
LSTA0.84%99.16%Net Selling
BLRX0.00%0.00%
SYBX5.53%94.47%Net SellingNet Selling
ATHA11.96%88.04%Net Selling
CVKD5.50%53.51%Net SellingNet Selling

Lisata Therapeutics Stock Ownership FAQ

Who owns Lisata Therapeutics?

Lisata Therapeutics (NASDAQ: LSTA) is owned by 8.38% institutional shareholders, 991.56% Lisata Therapeutics insiders, and 0.00% retail investors. Rimasia Capital Partners Manager Ltd is the largest individual Lisata Therapeutics shareholder, owning 24.63M shares representing 279.26% of the company. Rimasia Capital Partners Manager Ltd's Lisata Therapeutics shares are currently valued at $46.80M.

If you're new to stock investing, here's how to buy Lisata Therapeutics stock.
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.

Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.